Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis

Controlled Clinical Trials

Volumn 12, Issue 4 SUPPL., 1991, Pages

  Bennett, Kathryn ^a   Torrance, George ^a,b   Tugwell, Peter ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

clinical trials; n of 1 studies; Quality of life measures; rheumatoid arthritis; utility

Indexed keywords

DRUG;

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; FEASIBILITY STUDIES; HEALTH STATUS INDICATORS; HUMAN; PAIN MEASUREMENT; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0025900531     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(05)80017-0     Document Type: Article

References (21)

1. Issues in quality of life measurement in clinical Trials
2. Conference on Outcome Measures in Rheumatological Clinical Trials
3. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales
4. The AIMS approach to health status measurement properties
5. Preference for endpoint measures in clinical trials: Results of structured workshops
6. The MacTar patient preference questionnaire-An individual functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis
7. Auranofin therapy and quality of life in patients with rheumatoid arthritis
8. Measurement of health state utilities for economic appraisal
9. Utility approach to measuring health-related quality of life
10. Independent assessor and pooled index as techniques for measuring treatment effects in rheumatoid arthritis
11. Strategies for analyzing side effect data from SAFTEE: A workshop held in Rockville, Maryland
12. The hierarchy of quality-of-life assessment the Health Assessment Questionnaire (HAQ) and issues mandating development of a toxicity index
13. Measuring change over time: Assessing the usefulness of evaluative instruments
14. A methodologic framework for developing and selecting endpoints in clinical trials
15. Methodologic considerations in functional assessment
16. The Auranofin Cooperating Group A comparison of health status instruments for rheumatoid arthritis research
17. Scientific and clinical problems in indexes of functional disability
18. Measuring the well-being of family caregivers using the time trade-off technique
19. Should study subjects see their previous responses?